Data Led Prioritisation
by Guy's & St Thomas' NHS Foundation Trust
Covid-19 resulted in large backlogs with no way to manage risk of those waiting. Working in conjunction with Diabetologists, service leads and analytics, we have defined, coded and expertly validated clinical rulesets to objectively identify patients on waiting lists who may be deteriorating between appointments. We have identified >120 high-risk patients whose appointments we expedited based on their pathology tests. These patients are disproportionately represented by ethnic minority groups and areas of high deprivation. Clinical evaluation indicates that we prevented harm in ~40% of cases. This entry represents fast paced, award-winning digital innovation with real world impact for Diabetic patients.
"Guy’s & St Thomas; NHS Foundation Trust have produced an exceptional project. It is a simple concept, extremely well put together and is exciting. The technology is impressive and useful. It is easy to join up the information and looks to be not only innovative, but future proof. Patient feedback is strong and the judges could see that it is easily transferable, as well as reducing the workload for clinicians."
Hybrid Closed Loop Pilot in Adults: A Collaboration Between NHS England and ABCD DTN-UK
by NHS England and the Association of British Clinical Diabetologists Diabetes Technology Network UK
We describe the effective collaboration between NHS England and ABCD DTN-UK to deliver and evaluate the adult Hybrid Closed Loop (HCL) Pilot. The results have been presented at International Meetings and submitted for a high-impact publication. Most importantly, the data from 520 users was submitted to NICE, and made a significant impact to the cost-effectiveness evaluation to the NICE HCL multiple technology appraisal recommendations. This is currently in its draft form, with a full updated version being released soon and will enable improvement of care of for over 100,000 people living with Type 1 diabetes in England and Wales.
"The judges liked this well publicised, well balanced and well backed entry. It revolutionises healthcare from a patient perspective and had a lot of real-world data, demonstrating clear improvement in quality of life. It was slick, brilliant and, overall, an excellent project."